Cardiovascular Events in Parkinson's Disease Patients
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
Cardiovascular (CV) disease is a common comorbidity of Parkinson's disease (PD). The
background incidence rate of CV events in a levodopa-treated PD population was assessed to
better understand these comorbidities in the PD population. One objective of the study is to
identify a population of prevalent PD patients with incident levodopa use within the years
2004-2010 on the Integrated Health Care Information Services (IHCIS) database. The second
objective is to report the incidence of CV events overall and during intervals 0-6, 6-12 and
12-18 months after first prescription of levodopa among all new levodopa users.